Week of February 20, 2024 | Vol. 13, Issue 8

UPCOMING EVENTS

Events Hosted or Attended by Bourne Partners

Let's Meet!

Please reach out to Xan Smith to schedule a meeting with Bourne Partners in the following locations:

INDUSTRY M&A ACTIVITY

Recent Transactions, Trading Comps, Market Reports, M&A Pipeline

Recent Transactions

An Overview of Transactions Within Market Sub-segments

Below are summaries and charts with the past week's transactions from the different healthcare sectors. For a detailed table showing data for each industry transaction click on any of the charts. Total transaction values are provided in USD millions.

Trading Comps

A Breakdown of Relevant Trading Multiples

This is a high-level breakdown of median revenue and EBITDA multiples for each of the specific subsectors.

Market Research

Insight Into Healthcare Related Industries

Bourne Brief: Navigating Tailwinds & Headwinds in Clinical Research Service

Bourne Partners - Nov 2023

M&A Pipeline

Representative Current Retained Sell-Side and Partnering Opportunities

Project Ester

Consumer Health | Strategic Partnering 

Partnering opportunity for launch and commercialization of novel OTC dry eye product



Project Nirvana

Pharma | Capital Raise

Investment opportunity in sterile injectable pharmaceutical manufacturer and compounder

Project Panther

Pharma Services | Capital Raise

Investment opportunity in OTC and personal care CDMO

Project Trident

Pharma | Buy-Side

Seeking generic liquids or established brands across all formats sold through the hospital / institutional channel

Featured Headlines

A Sampling of Industry Headlines

As AI adoption in healthcare grows, Senate lawmakers weigh regulation, payment approaches

Fierce Healthcare - Feb 12, 2024

Multiply Labs and Thermo Fisher Scientific Expand Partnership to Automate Cell Expansion and Separation in Cell Therapy Manufacturing

Business Wire - Feb 12, 2024

Gilead Sciences Expands Liver Portfolio With Acquisition of CymaBay Therapeutics

Gilead - Feb 12, 2024

AbbVie concludes acquisition of ImmunoGen for $10.1bn

Pharmaceutical Technology - Feb 13, 2024

90,000 sq. ft. Expansion of Grand River Aseptic Manufacturing’s Finishing and Warehouse Center is Complete

GRAM - Feb 13, 2024

Biofourmis reels in 4 Big Pharma partnerships for cancer clinical trials

Fierce Biotech - Feb 14, 2024

Oracle extends CRO reach with AMS, Firma Clinical and EPS additions

Fierce Biotech - Feb 14, 2024

Selkirk Pharma Announces New APS Qualified Facility with Advanced Fill/Finish Capacity in Spokane, WA

Business Wire - Feb 15, 2024

INCOG BioPharma Services adds 100 million units of syringe/cartridge capacity

PR Newswire - Feb 15, 2024